A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.

NCT00287469 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2000

Enrollment

FED

Sponsor class

Conditions

Hepatitis

Interventions

BIOLOGICAL: Hepatitis E vaccine, recombinant (Sar 56 kDa)
OTHER: Placebo

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]
[object Object]